JP6192318B2 - シワ形成抑制剤及び/又は抗炎症剤のスクリーニング法 - Google Patents
シワ形成抑制剤及び/又は抗炎症剤のスクリーニング法 Download PDFInfo
- Publication number
- JP6192318B2 JP6192318B2 JP2013047508A JP2013047508A JP6192318B2 JP 6192318 B2 JP6192318 B2 JP 6192318B2 JP 2013047508 A JP2013047508 A JP 2013047508A JP 2013047508 A JP2013047508 A JP 2013047508A JP 6192318 B2 JP6192318 B2 JP 6192318B2
- Authority
- JP
- Japan
- Prior art keywords
- wrinkle formation
- inflammatory
- expression level
- test substance
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000037373 wrinkle formation Effects 0.000 title claims description 40
- 238000000034 method Methods 0.000 title claims description 36
- 238000012216 screening Methods 0.000 title claims description 21
- 239000003112 inhibitor Substances 0.000 title claims description 20
- 229940121363 anti-inflammatory agent Drugs 0.000 title claims description 10
- 239000002260 anti-inflammatory agent Substances 0.000 title claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 34
- 230000002757 inflammatory effect Effects 0.000 claims description 32
- 239000000126 substance Substances 0.000 claims description 31
- 230000014509 gene expression Effects 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 23
- 238000012360 testing method Methods 0.000 claims description 22
- 210000004027 cell Anatomy 0.000 claims description 21
- 210000001339 epidermal cell Anatomy 0.000 claims description 21
- -1 IL1α Proteins 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 7
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 6
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims description 5
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 5
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 claims description 5
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims description 5
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims description 5
- 101000852980 Homo sapiens Interleukin-23 subunit alpha Proteins 0.000 claims description 5
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 claims description 5
- 102000049772 Interleukin-16 Human genes 0.000 claims description 5
- 101800003050 Interleukin-16 Proteins 0.000 claims description 5
- 102100036705 Interleukin-23 subunit alpha Human genes 0.000 claims description 5
- 102100026894 Lymphotoxin-beta Human genes 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 5
- FOCAHLGSDWHSAH-UHFFFAOYSA-N difluoromethanethione Chemical compound FC(F)=S FOCAHLGSDWHSAH-UHFFFAOYSA-N 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 101000853009 Homo sapiens Interleukin-24 Proteins 0.000 claims description 4
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims description 4
- 108091058560 IL8 Proteins 0.000 claims description 4
- 102100036671 Interleukin-24 Human genes 0.000 claims description 4
- 102000004890 Interleukin-8 Human genes 0.000 claims description 4
- 108090001007 Interleukin-8 Proteins 0.000 claims description 4
- 102100040557 Osteopontin Human genes 0.000 claims description 4
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 claims description 4
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims description 4
- 230000001629 suppression Effects 0.000 claims description 2
- 230000037303 wrinkles Effects 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 102000016942 Elastin Human genes 0.000 description 5
- 108010014258 Elastin Proteins 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 210000004207 dermis Anatomy 0.000 description 5
- 229920002549 elastin Polymers 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000000440 neutrophil Anatomy 0.000 description 5
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 102000005741 Metalloproteases Human genes 0.000 description 4
- 108010006035 Metalloproteases Proteins 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 108010028275 Leukocyte Elastase Proteins 0.000 description 3
- 102000016799 Leukocyte elastase Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000019034 Chemokines Human genes 0.000 description 2
- 108010012236 Chemokines Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102000016387 Pancreatic elastase Human genes 0.000 description 2
- 108010067372 Pancreatic elastase Proteins 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003602 elastase inhibitor Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013047508A JP6192318B2 (ja) | 2013-03-11 | 2013-03-11 | シワ形成抑制剤及び/又は抗炎症剤のスクリーニング法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013047508A JP6192318B2 (ja) | 2013-03-11 | 2013-03-11 | シワ形成抑制剤及び/又は抗炎症剤のスクリーニング法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014171441A JP2014171441A (ja) | 2014-09-22 |
| JP2014171441A5 JP2014171441A5 (enExample) | 2016-04-14 |
| JP6192318B2 true JP6192318B2 (ja) | 2017-09-06 |
Family
ID=51693417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013047508A Active JP6192318B2 (ja) | 2013-03-11 | 2013-03-11 | シワ形成抑制剤及び/又は抗炎症剤のスクリーニング法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6192318B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7206725B2 (ja) * | 2018-09-14 | 2023-01-18 | ポーラ化成工業株式会社 | 肌状態改善剤のスクリーニング方法 |
| CN117357419B (zh) * | 2023-09-27 | 2025-11-28 | 花安堂生物科技集团有限公司 | 一种抗衰蛋白或其重组蛋白在制备化妆品中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007135510A (ja) * | 2005-11-21 | 2007-06-07 | Shiseido Co Ltd | Adam活性阻害剤のスクリーニング方法 |
| KR100879558B1 (ko) * | 2007-07-31 | 2009-01-22 | 라이브켐 주식회사 | 디벤조파라디옥신 유도체를 유효성분으로 함유한 피부보호 및 개선제 |
| JP2011101663A (ja) * | 2009-11-10 | 2011-05-26 | Shiseido Co Ltd | シワの形成し易さの評価方法 |
| JP2012250968A (ja) * | 2011-06-01 | 2012-12-20 | Momotani Juntendo:Kk | マトリックスメタロプロテアーゼ−1産生抑制剤及び/又はコラーゲン産生促進剤 |
-
2013
- 2013-03-11 JP JP2013047508A patent/JP6192318B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014171441A (ja) | 2014-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20110090803A (ko) | 화장품 조성물 | |
| CA2899701A1 (fr) | Utilisation d'une composition comprenant un perseose d'avocat dans la protection des cellules souches epidermiques | |
| KR20240161212A (ko) | 테트라셀미스 추출물 | |
| JP6192318B2 (ja) | シワ形成抑制剤及び/又は抗炎症剤のスクリーニング法 | |
| CN108653078B (zh) | 一种白桦树皮提取物及其提取方法和应用 | |
| JP6485836B2 (ja) | イグサ由来シクロオキシゲナーゼ−2阻害剤 | |
| JP5314372B2 (ja) | Mif分泌抑制剤 | |
| JP6424011B2 (ja) | 角栓形成抑制効果を有する素材のスクリーニング方法 | |
| JP2012051837A (ja) | グルタチオン産生促進剤 | |
| JP5362326B2 (ja) | Mif分泌抑制剤 | |
| JP6970952B2 (ja) | カリクレイン関連ペプチターゼ産生促進剤、lekti産生促進剤、slpi産生促進剤、角化正常化剤、コルネオデスモソーム分解正常化剤 | |
| JP2011162507A (ja) | 伸展刺激介在コラーゲン分解酵素生成抑制剤 | |
| JP6696097B2 (ja) | タルミ改善剤のスクリーニング法 | |
| JP2016135766A (ja) | カリクレイン関連ペプチターゼ産生促進剤、lekti産生促進剤、slpi産生促進剤、角化正常化剤、コルネオデスモソーム分解正常化剤 | |
| JP2019201602A (ja) | 低酸素条件下におけるocculudin遺伝子、claudin遺伝子及びzo−1遺伝子の発現量を指標とするスクリーニング方法、並びにclaudin遺伝子の発現低下抑制剤、細胞接着装置の機能低下抑制剤、及び皮膚バリア機能の低下の改善又は予防剤 | |
| JP5296466B2 (ja) | Mif分泌抑制剤 | |
| JP5864186B2 (ja) | 発毛促進剤 | |
| JP2024171544A (ja) | Mmp9遺伝子発現抑制剤、iv型コラーゲン分解抑制剤、及び皮膚外用組成物 | |
| JP2025084645A (ja) | 脂質産生抑制剤 | |
| JP5603457B2 (ja) | Mif分泌抑制剤 | |
| JP6142342B2 (ja) | アキノノゲシ抽出物の新規な用途 | |
| JP2023089811A (ja) | スクリーニング方法 | |
| JP2024088057A (ja) | 12型コラーゲン産生促進剤 | |
| JP2021195328A (ja) | KLK5 mRNA発現促進剤、KLK7 mRNA発現促進剤、SPINK5 mRNA発現促進剤、及び角層剥離改善剤又は角層剥離正常化剤、並びに皮膚化粧料 | |
| JP5552461B2 (ja) | Mif分泌抑制剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160224 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160224 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161221 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170110 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170725 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170808 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6192318 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |